Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Sep 5;106(1):124–133. doi: 10.1016/j.ijrobp.2019.08.057

Table 1.

Patient baseline demographics and disease characteristics (safety population)

Characteristic Result
Total eligible patients (n) 25
Age, y
 Median (range) 60 (47–77)
 Female, n (%) 9(36)
Race, n (%)
 Caucasian 23 (92)
 American Indian/Alaska Native 2(8)
Ethnicity, n (%)
 Hispanic 2 (8)
 Not Hispanic 23 (92)
ECOG PS, n (%)
 0 12 (48)
 1 13 (52)
Tumor location, n (%)
 Head/uncinate 23 (92)
 Body 1 (4)
 Tail 1 (4)
CA 19–9, U/mL, median (range)
 At baseline 561 (2–16,586)
Degree of vascular involvement, n (%)
 ≤ 180 SMV and/or PV only 7 (28)
 > 180 SMV and/or PV only 8 (32)
 ≤180 SMA only 2 (8)
 Arterial and venous combined 8 (32)

Abbreviations: CA = carbohydrate antigen; ECOG PS = Eastern Cooperative Oncology Group performance status; PV = portal vein; SD = standard deviation; SMA = superior mesenteric artery; SMV = superior mesenteric vein.